Authors: Naamah Maundrell, Future Science Group
LGC (Cambridge, UK) has developed a COVID-19 antibody assay that can analyze up to 40,000 samples daily and is suitable for both serum and dried blood sampling.
Serum or capillary blood can be collected remotely using Neoteryx’s (CA, USA) Mitra® microsampling device. The partnership enables individuals to collect their own blood sample at home using the Mitra device and a simple fingerstick method. The collected blood samples can be posted to LGC’s laboratory for SARS-CoV-2 testing.
This assay achieves a specificity of 100% and a sensitivity of 98% for samples taken 21 days post-positive PCR test. The testing also allows for sample results to be reported within 24 hours of sample receipt.